According to a market report by Lucintel, the future of the global aldose reductase inhibitor market looks promising with opportunities in the neural tissue, retina, kidney, and cardiovascular markets. The global aldose reductase inhibitor market is expected to reach an estimated $8 billion by 2030 at a CAGR of 5.8% from 2024 to 2030. The major drivers for this market are increasing prevalence of diabetic complications, rising demand for diabetic retinopathy treatments, and growing awareness about diabetic neuropathy.
A more than 150-page report to understand trends, opportunity and
forecast in global aldose reductase inhibitor market to 2030 by type (oral,
parenteral, and others), application (neural tissue, retina, kidney,
cardiovascular, and others), and region (North America, Europe, Asia Pacific,
and the Rest of the World).
Lucintel
forecasts that, within the type category, oral is expected to witness the
higher growth over the forecast period.
Within the
application category, neural tissue is expected to witness the highest growth.
Download
sample by clicking on aldose
reductase inhibitor market.
In terms
of region, APAC is expected to witness the highest growth over the forecast
period due to increased awareness of diabetic complications.
Alcon
Pharmaceuticals, Pfizer, Merck, Novartis, Sanofi, Boehringer Ingelheim, YZJ
Group, Applied Therapeutics, Abcam, TCI are the major suppliers in the aldose reductase inhibitor market.
This unique research
report will enable you to make confident business decisions in this globally
competitive marketplace. For a detailed table of contents, contact Lucintel at
+1-972-636-5056 or write us at helpdesk@lucintel.com. To get access of more than 1000 reports at fraction of cost
visit Lucintel's Analytics
Dashboard.
About Lucintel
At Lucintel, we offer solutions for
you growth through game changer ideas and robust market &
unmet needs analysis. We are based in
Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20
years. We are quoted in several publications like the Wall Street Journal,
ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
Autonomous Mining Equipment Market
Commercial Aircraft Emergency Generator Market
No comments:
Post a Comment